• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的新型抗 TNFα 环肽的设计、合成与生物活性。

Structure-Based Design, Synthesis and Bioactivity of a New Anti-TNFα Cyclopeptide.

机构信息

Institute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Aberdeen AB25 2ZD, UK.

Marine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Meston Walk, Aberdeen AB24 3UE, UK.

出版信息

Molecules. 2020 Feb 19;25(4):922. doi: 10.3390/molecules25040922.

DOI:10.3390/molecules25040922
PMID:32093030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7071015/
Abstract

As opposed to small molecules, macrocyclic peptides possess a large surface area and are recognised as promising candidates to selectively treat diseases by disrupting specific protein-protein interactions (PPIs). Due to the difficulty in predicting cyclopeptide conformations in solution, the de novo design of bioactive cyclopeptides remains significantly challenging. In this study, we used the combination of conformational analyses and molecular docking studies to design a new cyclopeptide inhibitor of the interaction between the human tumour necrosis factor alpha (TNFα) and its receptor TNFR-1. This interaction is a key in mediating the inflammatory response to tissue injury and infection in humans, and it is also an important causative factor of rheumatoid arthritis, psoriasis and inflammatory bowel disease. The solution state NMR structure of the cyclopeptide was determined, which helped to deduce its mode of interaction with TNFα. TNFα sensor cells were used to evaluate the biological activity of the peptide.

摘要

与小分子不同,大环肽具有较大的表面积,被认为是通过破坏特定的蛋白质-蛋白质相互作用(PPIs)来有选择性地治疗疾病的有前途的候选物。由于难以预测溶液中环肽的构象,因此生物活性环肽的从头设计仍然具有很大的挑战性。在这项研究中,我们使用构象分析和分子对接研究的组合来设计一种新的环肽抑制剂,用于抑制人肿瘤坏死因子α(TNFα)与其受体 TNFR-1 之间的相互作用。这种相互作用是介导人类组织损伤和感染的炎症反应的关键,也是类风湿关节炎、银屑病和炎症性肠病的重要致病因素。确定了环肽的溶液状态 NMR 结构,这有助于推断其与 TNFα 的相互作用模式。使用 TNFα 传感器细胞来评估肽的生物学活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/f7724d2bbb11/molecules-25-00922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/af4382711dc7/molecules-25-00922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/a6b53a293ab1/molecules-25-00922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/003d6f76503f/molecules-25-00922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/22f7f041a9fc/molecules-25-00922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/f7724d2bbb11/molecules-25-00922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/af4382711dc7/molecules-25-00922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/a6b53a293ab1/molecules-25-00922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/003d6f76503f/molecules-25-00922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/22f7f041a9fc/molecules-25-00922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/7071015/f7724d2bbb11/molecules-25-00922-g005.jpg

相似文献

1
Structure-Based Design, Synthesis and Bioactivity of a New Anti-TNFα Cyclopeptide.基于结构的新型抗 TNFα 环肽的设计、合成与生物活性。
Molecules. 2020 Feb 19;25(4):922. doi: 10.3390/molecules25040922.
2
Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification.基于计算设计与活性验证的靶向 TNFα-TNFR1 的环肽抑制剂的发现。
Molecules. 2024 Oct 31;29(21):5147. doi: 10.3390/molecules29215147.
3
Concise solid-phase synthesis enables derivatisation of YEATS domain cyclopeptide inhibitors for improved cellular uptake.简明固相合成使 YEATS 结构域环肽抑制剂得以衍生化,从而提高细胞摄取率。
Bioorg Med Chem. 2021 Sep 1;45:116342. doi: 10.1016/j.bmc.2021.116342. Epub 2021 Aug 2.
4
Rubipodanin A, the First Natural N-Desmonomethyl Rubiaceae-Type Cyclopeptide from Rubia podantha, Indicating an Important Role of the N9-Methyl Group in the Conformation and Bioactivity.茜草素A,一种从多花茜草中首次分离得到的天然N-去甲基茜草科型环肽,表明N9-甲基在构象和生物活性中起着重要作用。
PLoS One. 2015 Dec 22;10(12):e0144950. doi: 10.1371/journal.pone.0144950. eCollection 2015.
5
Design and synthesis of FAJANU: a de novo C(2) symmetric cyclopeptide family.FAJANU的设计与合成:一个全新的C(2)对称环肽家族
J Med Chem. 2008 Jun 12;51(11):3194-202. doi: 10.1021/jm800047b. Epub 2008 May 8.
6
Computational design and optimization of novel d-peptide TNFα inhibitors.新型 d-肽 TNFα 抑制剂的计算设计与优化。
FEBS Lett. 2019 Jun;593(12):1292-1302. doi: 10.1002/1873-3468.13444. Epub 2019 May 29.
7
Synthesis and biological properties of the seven alanine-modified analogues of the marine cyclopeptide hymenamide C.海洋环肽膜海鞘酰胺C的七种丙氨酸修饰类似物的合成及生物学特性
J Pept Sci. 2002 Aug;8(8):407-17. doi: 10.1002/psc.396.
8
Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide.半合成双环肽对肿瘤坏死因子α的亚基解离及抑制作用
Protein Eng Des Sel. 2015 Feb;28(2):45-52. doi: 10.1093/protein/gzu055.
9
Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.提出新型 TNFα 直接抑制剂骨架,使用基于片段对接的药效基团模型和基于二元 QSAR 的虚拟筛选协议流水线。
J Mol Graph Model. 2018 Oct;85:111-121. doi: 10.1016/j.jmgm.2018.07.007. Epub 2018 Aug 24.
10
Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.一种作为血管内皮生长因子与神经纤毛蛋白-1结合抑制剂的小环肽的设计、合成及体外生物学评价
Bioorg Med Chem Lett. 2016 Jun 15;26(12):2843-2846. doi: 10.1016/j.bmcl.2016.04.059. Epub 2016 Apr 21.

引用本文的文献

1
The Dual Role of TRADD in Liver Disease: From Cell Death Regulation to Inflammatory Microenvironment Remodeling.TRADD在肝脏疾病中的双重作用:从细胞死亡调控到炎症微环境重塑
Int J Mol Sci. 2025 Jun 19;26(12):5860. doi: 10.3390/ijms26125860.
2
Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts.破骨细胞激活与炎症性骨疾病:聚焦破骨细胞中的受体
J Inflamm Res. 2025 Mar 4;18:3201-3213. doi: 10.2147/JIR.S507269. eCollection 2025.
3
Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification.

本文引用的文献

1
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.通过稳定三聚体的不对称形式来抑制 TNF 信号的小分子。
Nat Commun. 2019 Dec 19;10(1):5795. doi: 10.1038/s41467-019-13616-1.
2
Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay.通过基于结构的虚拟筛选和生物学测定发现肿瘤坏死因子-α(TNF-α)和肿瘤坏死因子受体-1(TNF Receptor-1)的新型配体
J Chem Inf Model. 2017 May 22;57(5):1101-1111. doi: 10.1021/acs.jcim.6b00672. Epub 2017 May 11.
3
Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?
基于计算设计与活性验证的靶向 TNFα-TNFR1 的环肽抑制剂的发现。
Molecules. 2024 Oct 31;29(21):5147. doi: 10.3390/molecules29215147.
4
Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex.基于肽的变构抑制剂靶向 TNFR1 构象活性区域并使受体配体信号复合物失活。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2308132121. doi: 10.1073/pnas.2308132121. Epub 2024 Mar 29.
5
Carotenoids as potential inhibitors of TNFα in COVID-19 treatment.类胡萝卜素作为 COVID-19 治疗中 TNFα 的潜在抑制剂。
PLoS One. 2022 Dec 27;17(12):e0276538. doi: 10.1371/journal.pone.0276538. eCollection 2022.
6
A De Novo Optimized Cell-Free System for the Expression of Soluble and Active Human Tumor Necrosis Factor-Alpha.一种用于表达可溶性和活性人肿瘤坏死因子-α的全新优化无细胞系统。
Biology (Basel). 2022 Jan 19;11(2):157. doi: 10.3390/biology11020157.
7
Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells.肿瘤坏死因子-α及其受体 1 和 2 在与骨相关细胞中的相互作用的作用。
Int J Mol Sci. 2022 Jan 27;23(3):1481. doi: 10.3390/ijms23031481.
8
Rational Design of Constrained Peptides as Protein Interface Inhibitors.作为蛋白质界面抑制剂的受限肽的合理设计。
Antibodies (Basel). 2021 Aug 16;10(3):32. doi: 10.3390/antib10030032.
9
Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections.跨膜 TNF 及其受体 TNFR1 和 TNFR2 在分枝杆菌感染中的作用。
Int J Mol Sci. 2021 May 22;22(11):5461. doi: 10.3390/ijms22115461.
英夫利昔单抗和阿达木单抗的免疫原性:其在超敏反应以及治疗效果和安全性调节中起什么作用?
Expert Opin Drug Saf. 2016 Jan;15(1):43-52. doi: 10.1517/14740338.2016.1112375. Epub 2015 Nov 11.
4
Druggable protein-protein interactions--from hot spots to hot segments.可成药的蛋白-蛋白相互作用——从热点到热段。
Curr Opin Chem Biol. 2013 Dec;17(6):952-9. doi: 10.1016/j.cbpa.2013.10.011. Epub 2013 Oct 31.
5
Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction.基于结构的高亲和力环状肽模拟物设计,以阻断 MENIN-混合谱系白血病 1(MLL1)蛋白-蛋白相互作用。
J Med Chem. 2013 Feb 14;56(3):1113-23. doi: 10.1021/jm3015298. Epub 2013 Jan 17.
6
Synthesis of N-methylated cyclic peptides.N-甲基化环状肽的合成。
Nat Protoc. 2012 Feb 9;7(3):432-44. doi: 10.1038/nprot.2011.450.
7
The nuclear factor NF-kappaB pathway in inflammation.炎症中的核因子 NF-κB 通路。
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651. doi: 10.1101/cshperspect.a001651. Epub 2009 Oct 7.
8
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.抗 TNF 生物制剂:类风湿关节炎的首选治疗方法。
Nat Rev Rheumatol. 2009 Oct;5(10):578-82. doi: 10.1038/nrrheum.2009.181.
9
TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.肿瘤坏死因子-α作为炎症性疾病、缺血再灌注损伤和创伤的治疗靶点。
Curr Med Chem. 2009;16(24):3152-67. doi: 10.2174/092986709788803024.
10
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.英夫利昔单抗相关输注反应防治的综述与专家意见
Br J Dermatol. 2008 Sep;159(3):527-36. doi: 10.1111/j.1365-2133.2008.08728.x. Epub 2008 Jul 9.